Kevin W. Garey, Pharm.D., M.S., FASHP*
Professor and Chair
University of Houston
Kevin Garey, PharmD, MS, FASHP is a Professor at the University of Houston College of Pharmacy and Chair of the Department of Pharmacy Practice and Translational Research. He is an Adjunct Professor at the University of Texas School of Public Health and a Clinical Specialist and Researcher at Baylor St. Luke’s Medical Center, Houston, Texas. He received a Bachelor of Science in Pharmacy degree from Dalhousie University in Halifax, Nova Scotia, Canada, a Doctor of Pharmacy from SUNY Buffalo in Buffalo, NY, and a Masters of Science in Biometry from the University of Texas School of Public Health. Postdoctoral training includes a pharmacy practice residency at Bassett Healthcare, Cooperstown, NY and infectious disease specialty residency and fellowship training at the University of Illinois at Chicago, Chicago, IL.
Dr. Garey is a member of the Infectious Diseases Society of American (IDSA) Standards and Practice Guidelines Committee and is a member of the IDSA-Society of Healthcare Epidemiology of America (SHEA) practice guidelines for C. difficile infection. He is an active member of the Society of Infectious Diseases Pharmacists (SIDP) and the American Society of Health-system Pharmacists (ASHP). He has been awarded several national awards including the ASHP Best Practice Award in Health-system Pharmacy Administration (2010), the ASHP Drug Therapy Research Award (2007), and the SIDP Impact Paper in Infectious Diseases Pharmacotherapy Research Award (2007, 2012). He received the University of Houston PLS leadership award in 2013.
Dr. Garey's research, supported by the National Institute of Health, the Centers for Disease Control and Prevention, and the pharmaceutical industry involves clinical and translational research in healthcare associated infections including post-surgical infections, candidemia, and Clostridium difficile infection. He has published over 175 peer-reviewed articles including identification that a delay in therapy for patients with candidemia impacts mortality and identification of a genetic risk for C. difficile infection. *Content matter expert
Jerod Nagel, Pharm.D., BCPS-AQ ID*
Team Lead, Infectious Diseases & Antimicrobial Stewardship
University of Michigan Health System
Ann Arbor, Michigan
Dr. Nagel is currently the Pharmacy Lead for Antimicrobial Stewardship and Infectious Diseases at the University of Michigan Hospital and Health Systems. He directs the Infectious Diseases Residency Program Director and holds a faculty appointment as Clinical Assistant Instructor, and lectures for the School of Public Health, Nursing School and College of Pharmacy. Dr. Nagel graduated from Purdue University and completed his Infectious Diseases residency at Meriter Hospital in Madison, Wisconsin.
Dr. Nagel is a national leader in antimicrobial stewardship, and has published extensively on antimicrobial stewardship outcomes, including rapid diagnostics. He is currently the president of the Antimicrobial Stewardship in Cancer Consortium, lead his institution be recognized as an Antimicrobial Center of Excellence by the IDSA, and is active within IDSA, SHEA, SIDP and TJC committees that help promote antimicrobial stewardship.
*Content matter expert
Jason Schafer, Pharm.D., M.P.H., BCPS-AQ ID, AAHIVP
Professor and Vice Chair, Department of Pharmacy Practice
Jefferson College of Pharmacy, Thomas Jefferson University
Jason is a Professor and the Vice Chair of the Department of Pharmacy Practice at the Jefferson College of Pharmacy and Clinical Pharmacy Specialist in HIV Medicine at the Thomas Jefferson University in Philadelphia, Pennsylvania.
Jason received his Doctor of Pharmacy degree from Duquesne University. He completed a pharmacy practice residency at UPMC Mercy Hospital in Pittsburgh and an infectious diseases specialty residency at the Ohio State University Wexner Medical Center. He received his Master of Public Health degree from the Jefferson College of Population Health. *Content matter expert
Samuel L. Aitken, Pharm.D., BCPS -AQ ID
Clinical Pharmacy Specialist - Infectious Diseases
Division of Pharmacy, The University of Texas MD Anderson Cancer Center
Samuel L. Aitken, PharmD received his pharmacy degree from the University at Buffalo School of Pharmacy and Pharmaceutical Sciences in 2011. He completed his pharmacy practice residency at Yale-New New Haven Hospital and an infectious diseases pharmacotherapy fellowship at the University of Houston / Baylor St. Luke’s Medical Center. He is currently a clinical pharmacy specialist in infectious diseases and program director of the PGY-2 Infectious Diseases Pharmacy residency at the University of Texas MD Anderson Cancer Center with an active role in patient care and education of post-graduate pharmacy and medical trainees. His research is focused on the epidemiology, molecular mechanisms, and treatment of multidrug-resistant bacterial infections in patients with hematologic malignancy. Additionally, Dr. Aitken is the founding chair of the Antimicrobial Stewardship in Cancer Consortium (ASCC), a group dedicated to advancing antimicrobial stewardship research and practice in cancer patients.
Melissa Badowski, Pharm.D., M.P.H., BCPS, AAHIVP
Clinical Associate Professor
University of Illinois at Chicago, College of Pharmacy
Melissa Badowski, Pharm.D., M.P.H., AAHIVP, BCPS is Clinical Associate Professor at the University of Illinois at Chicago, College of Pharmacy in Chicago, Illinois. Dr. Badowski received her doctorate of pharmacy degree from Midwestern University, Chicago College of Pharmacy, Downers Grove, Illinois. She completed her PGY-1 pharmacy practice and PGY-2 pharmacotherapy residencies at the University of Maryland Medical Center and the University of Maryland College of Pharmacy, Baltimore, Maryland. Her specialties and research interests include HIV, HCV, and Infectious Diseases. In 2010, Dr. Badowski joined the University of Illinois at Chicago, College of Pharmacy, Chicago, Illinois, where she is currently a Clinical Associate Professor in the Section of Infectious Diseases Pharmacotherapy. Her practice sites include a telemedicine clinic managing HIV infected prisoners throughout the state of Illinois and an infectious diseases clinic.
Steven Ebert, B.S.Pharm., Pharm.D., FCCP, FIDSA
Clinical Pharmacy Manager, Infectious Diseases
UnityPoint Health-Meriter Hospital
Clinical Professor of Pharmacy
University of Wisconsin, Madison
Steven Ebert, Pharm.D., FIDSA, FCCP is Clinical Manager in Infectious Diseases at Meriter Hospital and Clinical Professor of Pharmacy, University of Wisconsin, Madison. He received his B.S. in Pharmacy from the University of Wisconsin in 1979. He subsequently received his Pharm.D. at the University of Texas-Austin, and completed a residency in infectious diseases at the University of Texas Health Sciences Center at San Antonio. His practice and research interests are antimicrobial resistance, antimicrobial pharmacokinetics/pharmacodynamics, and appropriate utilization of healthcare resources. Dr. Ebert has served as a member of the Board of Directors of the Pharmacy Society of Wisconsin (PSW), Chairman of PSW’s Hospital Pharmacy Advisory Board, Chairman of WARN (Wisconsin Antibiotic Resistance Network), and as President of the Society of Infectious Diseases Pharmacists. He is a Fellow of the American College of Clinical Pharmacy and the Infectious Diseases Society of America. He served as a member of the FDA Antiinfective Drug Advisory Committee from 2001-4. Dr. Ebert has published over 50 original research articles, review articles, and book chapters on optimizing antimicrobial use and dosing regimens.
Julie Harting, Pharm.D.
Associate Professor, Clinical & Administrative Sciences
Sullivan University College of Pharmacy
Clinical Pharmacist Specialist, Infectious Disease
Julie Harting, Pharm.D., is an Associate Professor in the Department of Clinical and Administrative Sciences at Sullivan University College of Pharmacy and Health Sciences, and a Clinical Pharmacist Specialist (Infectious Disease) at University Hospital, both in Louisville, Kentucky. In addition, Dr. Harting is a Faculty member with the University of Louisville Division of Infectious Disease and has collaborated on clinical research projects primarily focusing on bone and joint infections. This affiliation also created an opportunity for academic lectures to the University of Louisville Internal Medicine Residency Program as part of the Louisville Lectures series. Dr. Harting completed her Infectious Disease PGY-2 residency training in 2009 and a Making a Difference in Infectious Disease (MAD-ID) Antimicrobial Stewardship Certification in 2010. In the clinical setting, she manages consult patients on the Bone & Joint Infectious Disease ervice and supports hospital-wide antimicrobial stewardship efforts including contributions to the SubCommittee for Antimicrobial Stewardship.
Angela Huang, Pharm.D., BCPS
Clinical Pharmacy Specialist, Infectious Diseases
Froedtert & The Medical College of Wisconsin
Angie Huang, Pharm.D., BCPS, is an Infectious Diseases Clinical Pharmacist and Program Director for the PGY-2 Infectious Diseases Pharmacy Residency at Froedtert & The Medical College of Wisconsin, Milwaukee, Wisconsin. Dr. Huang completed her Pharm.D. at Drake Univeristy, then went on to do a PGY-1 residency at University of Nebraska Medical Center and a PGY-2 Infectious Diseases Pharmacy Residency at University of Michigan Hospitals. She currently supports the infectious diseases consult services at Froedtert, as well as antimicrobial stewardship, precepting and clinical research. Her areas of interest include rapid diagnostic testing and viral infections in bone marrow transplant.
Krystal Moorman, Pharm.D., BCPS
Director Experiential Education and Assistant Clinical Professor
University of Utah College of Pharmacy
Salt Lake City, Utah
Krystal Moorman, PharmD, BCPS, is an Assistant Clinical Professor in the Department of Pharmacotherapy at the University of Utah College of Pharmacy, Salt Lake City, Utah. Dr. Moorman is currently a Clinical Assistant Professor in the University of Utah College of Pharmacy Department of Pharmacotherapy. She is also the Director of Experiential Education for the University. Dr. Moorman earned her doctor of pharmacy degree from the Medical University of South Carolina College of Pharmacy. She then completed a PGY-1 residency at the Medical University of South Carolina as well as a PGY-2 residency in Drug Information Practice. Prior to joining the University of Utah, Dr. Moorman served as the Coordinator of Drug Information and Medication Safety at Intermountain Medical Center for 4 years. She has also worked as a Drug Information Specialist at Kaiser Permanente in Denver, Colorado. Her interests include drug information, medication safety, and experiential education.
J. Nicholas O'Donnell, Pharm.D., M.Sc., BCPS
Albany College of Pharmacy and Health Sciences
Albany, New York
John Nicholas O'Donnell, Pharm.D., M.Sc., BCPS, is Assistant Professor at Albany College of Pharmacy and Health Sciences, Albany, New York. He earned a Doctor of Pharmacy degree at Northeastern University, Boston, Massachusetts, and his Master of Science in Clinical Investigation at Northwestern University, Chicago, Illinois. Dr. O’Donnell’s specialized training includes an Infectious Diseases Pharmacotherapy Fellowship at Midwestern University, Downer’s Grove, Illinois and Northwestern Medicine, Chicago, Illinois, and a PGY-1 Residency at Beth Israel Deaconess Medical Center, Boston, Massachusetts. His research and practice interests include PK/PD of bacterial agents and optimal treatment of multi-drug resistant Gram-negative organisms.
Natasha Pettit, Pharm.D., BCPS-AQ ID
Clinical Pharmacy Specialist, Infectious Diseases
The University of Chicago Medicine
Natasha N. Pettit, Pharm.D., BCPS-AQ ID, is an Infectious Diseases Clinical Pharmacy Specialist at the University of Chicago Medicine (UCM), where she has been practicing since completing her pharmacy residency training in 2010 at the University of Michigan Hospitals and Health Centers (2008-2010). She earned her Doctorate of Pharmacy degree at the University of the Pacific, Stockton, California, in 2008. Her current roles include Pharmacy Director of the Antimicrobial Stewardship Program, Clinical Pharmacy Coordinator for Infectious Diseases Pharmacy Services, and Director of the Postgraduate Year 2 Pharmacy Residency in Infectious Diseases at UCM. Dr. Pettit provides clinical pharmacy support to the Infectious Disease consult services, oversees antimicrobial stewardship monitoring/activities, and is involved with several committees and quality initiatives at UCM focused on ensuring safe and judicious use of antimicrobials. Dr. Pettit has several research interests including assessing the impact of antimicrobial stewardship interventions, the impact of rapid diagnostics on antimicrobial prescribing, infection management in the immune-compromised host, treatment strategies for multi-drug resistant infections, and use of technology to optimize stewardship impact. She also provides education on antimicrobial management and stewardship practices through her involvement in the training of pharmacy/medical students and residents, Infectious Diseases fellows, and serving as a faculty member for the Society of Infectious Diseases Pharmacists (SIDP) Antimicrobial Stewardship Certificate Program for Pharmacists.
Kyana D. Stewart, Pharm.D., M.S., BCPS
Clinical Pharmacy Specialist
Ochsner Medical Center
New Orleans, Louisiana
Dr. Stewart is a Clinical Pharmacy Specialist in Infectious Diseases at Ochsner Medical Center. In her current role she works collaboratively with other ID Clinical Specialists to provide infectious diseases pharmacotherapy support to the Ochsner Infectious Diseases consult services as well as contributing to the growth and expansion of the antimicrobial stewardship program at Ochsner Medical Center. She earned her B.S. in Chemistry from Southern University and A&M College (Baton Rouge, LA), her M.S. in Environmental Engineering from University of Florida (Gainesville, FL), and her Doctor of Pharmacy from the University of Houston College of Pharmacy (Houston, TX).
She completed PGY 1 residency training at Huntsville Hospital System (Huntsville, AL). Prior to joining Ochsner she has served in multiple roles including Clinical Specialist Pharmacist in HIV/AIDS care and Antimicrobial Stewardship with Parkland Health and Hospital System Jail health services, Antimicrobial Stewardship Program Co - Chair (Children’s Medical Center - Dallas), Clinical Instructor (UTSW Medical School), and Assistant Professor of Pharmacy Practice (Texas Tech University Health Sciences Center) all leading to the implementation & enhancement of antimicrobial stewardship programs and provision of didactic and experiential learning experiences for pharmacy and medical students, residents, & fellows. Primary clinical interests are optimization of PK/PD of antimicrobial agents in special populations (pediatrics & immunocompromised hosts), antimicrobial impacts on gut microbiome diversity, and strategies to enhance and develop antimicrobial stewardship in resources limited settings.
Kayla Stover, Pharm.D., BCPS-AQ ID, FCCP, FIDSA
University of Mississippi School of Pharmacy
Dr. Kayla R. Stover is an associate professor of pharmacy practice at the University of Mississippi in Jackson, Mississippi, and an affiliated faculty in the Department of Medicine-Infectious Diseases and the Department of Pharmacology at the University of Mississippi Medical Center. She is a Board Certified Pharmacotherapy Specialist with Added Qualifications in Infectious Diseases. Dr. Stover was a founding member of the antimicrobial stewardship program at the university medical center. In addition to her clinical practice in infectious diseases, Dr. Stover has been the Infectious Diseases Residency Program Director since 2012. Areas of research interest include antifungal pharmacotherapy and safety and antimicrobial stewardship and resistance.
Dr. Stover received her Pharm.D. from Ohio Northern University in 2007, completed her PGY1 Pharmacy Practice Residency at West Virginia University Hospitals in 2008, and her PGY2 Infectious Diseases Residency at the University of Mississippi Medical Center in 2009. She was named as a Fellow of both the American College of Clinical Pharmacy and the Infectious Diseases Society of America in 2017.
Marylee Worley, Pharm.D., BCPS
Nova Southeastern University
Marylee Worley received her Doctor of Pharmacy from Temple University School of Pharmacy in Philadelphia, Pennsylvania. Prior to pharmacy school, Dr. Worley received her Bachelors of Science in Biochemistry from Virginia Tech in Blacksburg, Virginia. She completed a PGY-1 Pharmacy Practice Residency at Palmetto General Hospital in Miami, Florida, followed by a PGY-2 Infectious Disease Pharmacy Residency at Lee Health in Fort Myers, Florida. Dr. Worley currently teaches infectious disease pharmacotherapy as well as an elective in antimicrobial stewardship as an assistant professor of pharmacy practice at Nova Southeastern University College of Pharmacy.
Evan Zasowski, Pharm.D., M.P.H., BCPS
Clinical Assistant Professor
University of Houston College of Pharmacy
Evan Zasowski, Pharm.D., BCPS, is a Clinical Assistant Professor in the Department of Pharmacy Practice and Translational Research at University of Houston College of Pharmacy. Dr. Zasowski obtained his Doctor of Pharmacy from Albany College of Pharmacy. Following graduation, he accepted a one-year postdoctoral research appointment at Albany College of Pharmacy before completing a PGY-1 residency at The University of Chicago Medicine. He subsequently completed a postdoctoral research fellowship in infectious diseases outcomes in the Anti-Infective Research Laboratory at Wayne State University, Detroit, Michigan. His clinical and research interests involve invasive multidrug-resistant bacterial infections, primarily methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci. His work focuses on optimizing patient outcomes of multidrug-resistant infections through development and evaluation of novel diagnostic and treatment paradigms.